WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006125178) TRICYCLIC PYRIDAZINE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/125178    International Application No.:    PCT/US2006/019550
Publication Date: 23.11.2006 International Filing Date: 19.05.2006
IPC:
C07D 487/04 (2006.01), C07D 498/04 (2006.01), A61K 31/5513 (2006.01), A61K 31/553 (2006.01), A61P 3/06 (2006.01)
Applicants: XENON PHARMACEUTICALS INC. [CA/CA]; 3650 Gilmore Way, Burnaby, British Columbia V5G 4W8 (CA) (For All Designated States Except US).
HOU, Duanjie [CA/CA]; (CA) (For US Only).
ROTH, Carol, J. [US/US]; (US) (OM only)
Inventors: HOU, Duanjie; (CA)
Agent: ROTH, Carol, J.; Seed Intellectual Property Law Group PLLC, Suite 6300, 701 Fifth Avenue, Seattle, WA 98104-7092 (US)
Priority Data:
60/682,511 19.05.2005 US
Title (EN) TRICYCLIC PYRIDAZINE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
(FR) COMPOSES DE PYRIDAZINE TRICYCLIQUES ET LEURS UTILISATIONS COMME AGENTS THERAPEUTIQUES
Abstract: front page image
(EN)Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I) where Ar, p, J, K, L, Q, W, V, R3, R4 and R5 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
(FR)L'invention porte sur des méthodes de traitement d'une maladie ou état induit par SCD chez un mammifère, de préférence un être humain. Ces méthodes consistent à administrer à un mammifère un composé de formule (I) dans laquelle Ar, p, J, K, L, Q, W, V, R3, R4 et R5 sont tels que définis dans la demande. L'invention porte également sur des compositions pharmaceutiques comprenant les composés de formule (I).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)